Stage 4 Lung Cancer EGFR Survival Rate | Patient Guide
Lung cancer leads in causing deaths from cancer in the United States. Its overall 5-year survival rate is only 16.8%. […]
Targeted Therapy
Understanding KRAS Mutation in Lung Cancer
About 25% of lung cancer patients are affected by KRAS mutations. This fact highlights the role of KRAS gene mutations
Unlocking Lung Cancer Immunotherapy Potential
Lung cancer is the top cause of cancer deaths around the world, with over 1.8 million people dying each year.
Treatment of Non Small Cell Lung Cancer Options Today
Did you know that 234,580 new cases of lung cancer are expected in the U.S. in 2024? This number includes
Living with EGFR Lung Cancer Stage 4: Treatment Guide
Did you know about half of lung cancers in young adults come from EGFR mutations? This fact underlines the need
Trodelvy Lung Cancer: Latest Treatment Breakthrough
Did you know over 80% of non-small cell lung cancer (NSCLC) patients show PD-L1 tumor scores under 50%? This fact
Is Stage 4 Lung Cancer Treatable: Treatment Options Today
Did you know that over 225,000 Americans are diagnosed with lung cancer each year? By the time it gets to
ALK-Positive Metastatic NSCLC: Treatment Guide
Did you know 3 to 5 percent of non-small cell lung cancer (NSCLC) tumors have changes in the ALK gene?
Driver Mutations in Lung Cancer: What You Need to Know
Up to 30% of non-small cell lung cancer (NSCLC) patients carry mutations in the KRAS gene. This makes KRAS the
Tagrisso Lung Cancer: Treatment Guide for Patients
Did you know about 70% of lung cancer patients in the U.S. have advanced non-small cell lung cancer (NSCLC)? Tagrisso